Efficacy of submucosal lidocaine injection for shortening procedure time of endoscopic submucosal dissection (ESD) for the treatment of the gastric and colorectal tumor.

Efficacy of submucosal lidocaine injection for shortening procedure time of endoscopic submucosal dissection (ESD) for the treatment of the gastric and colorectal tumor. - Efficacy of submucosal lidocaine injection when performing ESD for the gastric and colorectal tumor.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022843

Enrollment

240

Registered

2016-06-22

Start date

2015-11-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric and colorectal tumor which will be removed by ESD.

Interventions

Submucosal injection of lidocaine. Submucosal injection of saline.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with gastric or colorectal tumor which will be removed by ESD.

Exclusion criteria

Exclusion criteria: 1. Severe cardiac disease. 2. Severe kidney disease. 3. Severe infectious disease. 4, Severe diabetes. 5. Severe psychiatric disease. 6. Severe dehydration and nutritional disorder. 7. Patients with bleeding disorders. 8. Patients with severe complications who were determined to be inappropriate to carry out the study. 9. History of hypersensitivity to lidocaine. 10. Patients with tumors which cannot be removed by ESD.

Design outcomes

Primary

Measure	Time frame
The procedure time of ESD between lidocaine injected group and control group.	—

Countries

Japan

Contacts

Public ContactMasami Ijiri

Asahikawa Medical University Division of Gastroenterology and Hematology/Oncology, Department of Medicine

m-ijiri@asahikawa-med.ac.jp0166-68-2462

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026